AtezoTRIBE Update
AtezoTRIBE: Updated Results of First-line Treatment With FOLFOXIRI + Bevacizumab ± Atezolizumab for Unresectable Metastatic Colorectal Cancer

Released: June 08, 2023

Activity

Progress
1
Course Completed